ilShinbiobase Co. Ltd (068330) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.053x

Based on the latest financial reports, ilShinbiobase Co. Ltd (068330) has a cash flow conversion efficiency ratio of 0.053x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩3.46 Billion ≈ $2.34 Million USD) by net assets (₩65.35 Billion ≈ $44.29 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of ilShinbiobase Co. Ltd to measure how much of total assets are equity-financed.

ilShinbiobase Co. Ltd - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how ilShinbiobase Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check ilShinbiobase Co. Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.

ilShinbiobase Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of ilShinbiobase Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Asian Hotels (East) Limited NSE:AHLEAST	0.039x
Worth Peripherals Limited NSE:WORTH	0.067x
HI SPAC 3 KQ:217500	-0.025x
Athira Pharma Inc NASDAQ:ATHA	-0.698x
Brookside Energy Ltd AU:BRK	0.108x
Haatz Inc KQ:066130	0.000x
Perusahaan Sadur Timah Malaysia Perstima Bhd KLSE:5436	0.069x
Syntara Ltd AU:SNT	-0.694x

Annual Cash Flow Conversion Efficiency for ilShinbiobase Co. Ltd (2014–2025)

The table below shows the annual cash flow conversion efficiency of ilShinbiobase Co. Ltd from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see ilShinbiobase Co. Ltd (068330) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩64.80 Billion ≈ $43.91 Million	₩5.27 Billion ≈ $3.57 Million	0.081x	+19.22%
2024-12-31	₩60.45 Billion ≈ $40.97 Million	₩4.12 Billion ≈ $2.79 Million	0.068x	-34.34%
2023-12-31	₩57.06 Billion ≈ $38.67 Million	₩5.92 Billion ≈ $4.01 Million	0.104x	+111.12%
2022-12-31	₩53.82 Billion ≈ $36.47 Million	₩2.65 Billion ≈ $1.79 Million	0.049x	-63.21%
2021-12-31	₩50.47 Billion ≈ $34.20 Million	₩6.74 Billion ≈ $4.57 Million	0.134x	+31.71%
2020-12-31	₩44.38 Billion ≈ $30.08 Million	₩4.50 Billion ≈ $3.05 Million	0.101x	-26.55%
2019-12-31	₩40.16 Billion ≈ $27.22 Million	₩5.55 Billion ≈ $3.76 Million	0.138x	+1.17%
2018-12-31	₩35.72 Billion ≈ $24.20 Million	₩4.88 Billion ≈ $3.31 Million	0.137x	+127.43%
2017-12-31	₩35.22 Billion ≈ $23.87 Million	₩2.11 Billion ≈ $1.43 Million	0.060x	-34.18%
2016-12-31	₩32.98 Billion ≈ $22.35 Million	₩3.01 Billion ≈ $2.04 Million	0.091x	+719.39%
2015-12-31	₩24.27 Billion ≈ $16.45 Million	₩270.22 Million ≈ $183.12K	0.011x	-91.87%
2014-12-31	₩24.30 Billion ≈ $16.47 Million	₩3.33 Billion ≈ $2.25 Million	0.137x	--

About ilShinbiobase Co. Ltd

KQ:068330 Korea

Market Cap

$26.59 Million

₩39.24 Billion KRW

Market Cap Rank

#24174 Global

#1682 in Korea

Share Price

₩941.00

Change (1 day)

-5.71%

52-Week Range

₩941.00 - ₩998.00

All Time High

₩998.00